Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00233987

Public ClinicalTrials.gov record NCT00233987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Tandem Autologous Stem Cell Transplantation for Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy with a peripheral stem cell transplant may allow more chemotherapy to be given so that more cancer cells are killed. Tandem (two) autologous stem cell transplants may be an effective treatment for Hodgkin's lymphoma. PURPOSE: This phase II trial is studying how well tandem stem cell transplantation works in treating patients with progressive or recurrent Hodgkin's lymphoma.

Study identification

NCT ID
NCT00233987
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
98 participants

Conditions and interventions

Eligibility (public fields only)

Age range
15 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2005 (Type not available)
Primary completion
Nov 2014 (Actual)
Completion
Dec 2017 (Actual)
Last update posted
Mar 1, 2018

2005 – 2017

United States locations

U.S. sites
53
U.S. states
8
U.S. cities
34
Facility City State ZIP Site status
University of California Davis Cancer Center Sacramento California 95817 —
Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise Idaho 83712 —
Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood Illinois 60153 —
Cancer Center of Kansas, PA - Chanute Chanute Kansas 66720 —
Cancer Center of Kansas, PA - Dodge City Dodge City Kansas 67801 —
Cancer Center of Kansas, PA - El Dorado El Dorado Kansas 67042 —
Cancer Center of Kansas-Independence Independence Kansas 67301 —
Cancer Center of Kansas, PA - Kingman Kingman Kansas 67068 —
Southwest Medical Center Liberal Kansas 67901 —
Cancer Center of Kansas, PA - Newton Newton Kansas 67114 —
Cancer Center of Kansas, PA - Parsons Parsons Kansas 67357 —
Cancer Center of Kansas, PA - Pratt Pratt Kansas 67124 —
Cancer Center of Kansas, PA - Salina Salina Kansas 67042 —
Cancer Center of Kansas, PA - Wellington Wellington Kansas 67152 —
Associates in Womens Health, PA - North Review Wichita Kansas 67208 —
Cancer Center of Kansas, PA - Medical Arts Tower Wichita Kansas 67208 —
Cancer Center of Kansas, PA - Wichita Wichita Kansas 67214 —
CCOP - Wichita Wichita Kansas 67214 —
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214 —
Cancer Center of Kansas, PA - Winfield Winfield Kansas 67156 —
Tulane Cancer Center Office of Clinical Research Alexandria Louisiana 71315-3198 —
Legacy Mount Hood Medical Center Gresham Oregon 97030 —
Providence Milwaukie Hospital Milwaukie Oregon 97222 —
Legacy Good Samaritan Hospital & Comprehensive Cancer Center Portland Oregon 97210 —
Providence Cancer Center at Providence Portland Medical Center Portland Oregon 97213-2967 —
Adventist Medical Center Portland Oregon 97216 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
Providence St. Vincent Medical Center Portland Oregon 97225 —
Legacy Emanuel Hospital and Health Center and Children's Hospital Portland Oregon 97227 —
Legacy Meridian Park Hospital Tualatin Oregon 97062 —
Thompson Cancer Survival Center Knoxville Tennessee 37916 —
Auburn Regional Center for Cancer Care Auburn Washington 98002 —
St. Joseph Cancer Center Bellingham Washington 98225 —
Olympic Hematology and Oncology Bremerton Washington 98310 —
Providence Centralia Hospital Centralia Washington 98531-9027 —
St. Francis Hospital Federal Way Washington 98003 —
Columbia Basin Hematology Kennewick Washington 99336 —
Providence St. Peter Hospital Regional Cancer Center Olympia Washington 98506-5166 —
Good Samaritan Cancer Center Puyallup Washington 98372 —
Fred Hutchinson Cancer Research Center Seattle Washington 98104 —
Harborview Medical Center Seattle Washington 98104 —
Minor and James Medical, PLLC Seattle Washington 98104 —
Group Health Central Hospital Seattle Washington 98112 —
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98122-4307 —
Polyclinic First Hill Seattle Washington 98122 —
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043 —
Cancer Care Northwest - Spokane South Spokane Washington 99202 —
Franciscan Cancer Center at St. Joseph Medical Center Tacoma Washington 98405-3004 —
Allenmore Hospital Tacoma Washington 98405 —
CCOP - Northwest Tacoma Washington 98405 —
MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma Washington 98405 —
St. Clare Hospital Tacoma Washington 98499 —
Southwest Washington Medical Center Cancer Center Vancouver Washington 98668 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00233987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2018 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00233987 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →